Clinical Trial: Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC

U.S., Nov. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07232654) titled 'Iparomlimab/Tuvonralimab Injection Plus CCRT in LACC' on Nov. 14.

Brief Summary: This study is a clinical study to evaluate the safety and efficacy of Iparomlimab/Tuvonralimab Injection (QL1706, a Bifunctional Mabpair Product of Anti-PD-1 and Anti-CTLA-4 Antibodies) in Combination With Concurrent Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer.

Study Start Date: Nov. 10

Study Type: INTERVENTIONAL

Condition: LOCALLY ADVANCED CERVICAL CANCERS

Intervention: DRUG: Iparomlimab/Tuvonralimab

IV infusion

DRUG: Cisplatin

IV infusion

RADIATION: Brachytherapy and External Beam Radiotherapy

Radiation

Recruitment ...